Munich - Delayed Quote • EUR Medincell SA (MEB.MU) Follow Add holdings 15.15 -0.21 (-1.37%) At close: May 14 at 8:03:25 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for MEB.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: MEB.MU View More All News Press Releases SEC Filings UZEDY® Continues Strong Momentum in 2025; Olanzapine LAI on Track for FDA Filing in H2 2025 European Growth Companies With High Insider Ownership In April 2025 3 European Stocks Estimated To Be Trading Below Fair Value By Up To 49.4% Medincell and iM4TB Initiate Development of a Long-Acting Injectable Version of Macozinone, a Promising Investigational Tuberculosis Treatment Medincell Increases the Amount Allocated to the Liquidity Contract with Rothschild Martin Maurel Medincell’s Partner Teva Presented Phase 3 Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with Olanzapine LAI European Growth Stocks With High Insider Ownership March 2025 European Stocks Estimated To Be Trading Below Intrinsic Value By Up To 47.5% Medincell Strengthens its Board of Directors to Support its Growth 3 European Growth Companies With Up To 19% Insider Ownership Medincell to Present at the TD Cowen 45th Annual Healthcare Conference, March 3-5, 2025, Boston, MA